| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.089 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.03 | 0.6 |